Acknowledgment Omitted: In the Preliminary
Communication entitled "Preliminary Assessment of Inhaled Nitric Oxide for
Acute Vaso-occlusive Crisis in Pediatric Patients With Sickle Cell Disease"
published in the March 5, 2003, issue of JAMA (2003;289:1136-1142), an acknowledgment
was omitted. The authors acknowledge that their protocol was initially developed
in collaboration with C. Alvin Head, MD, the principal investigator for the
multicenter Sickle Cell Inhaled Nitric Oxide Study (SCINOS) evaluating nitric
oxide for the treatment of sickle cell vaso-occlusive crisis in adult and
pediatric patients. Dr Head was not involved in the procurement of US Food
and Drug Administration funding, study implementation or conduct, patient
enrollment, data collection, data analysis, or manuscript preparation or review.
Preliminary Assessment of Inhaled Nitric Oxide for Acute Vaso-occlusive Crisis in Pediatric Patients With Sickle Cell Disease—Correction. JAMA. 2004;292(8):925. doi:10.1001/jama.292.8.925